First Case of Candidemia Caused by Fluconazole-Resistant Candida orthopsilosis Harboring the ERG11 G458S Mutation in a Hematopoietic Stem Cell Transplant Recipient in Asia
Mycopathologia · 2026-08 · 191 (4)
DOI: 10.1007/s11046-026-01093-2 ↗Kurz gefasst
Fallbericht in der Zeitschrift Mycopathologia, online erschienen am 23.07.2026. Verfasst von Tatsuro Hirao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan. Hauptthemen laut MEDLINE: Candidemia, Fluconazole, Antifungal Agents, Drug Resistance, Fungal. Die Arbeit nennt 16 Literaturangaben. Gefördert von: AMED, Okinaka Memorial Institute for Medical Research.
Abstract (Originalsprache)
Candidemia poses a life-threatening complication for immunocompromised patients, including those undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Non-albicans Candida species are increasingly recognized as causative pathogens in this population, with azole resistance having emerged as a global concern. Candida orthopsilosis, a member of the Candida parapsilosis species complex, is generally considered susceptible to azole antifungal agents. Although sporadic reports of azole-resistant isolates have surfaced worldwide, no such cases have been documented in Japan. Furthermore, genetic evaluations of azole-resistant C. orthopsilosis have primarily been conducted in Europe. We present the first case of fluconazole-resistant C. orthopsilosis bloodstream infection in a 73-year-old man following allo-HSCT for acute myeloid leukemia in Japan. Whole-genome sequencing identified an ERG11 G458S substitution, a known mechanism of fluconazole resistance in C. orthopsilosis, representing the first identification of this mutation outside Europe. Our findings highlight the importance of continued surveillance of antifungal resistance in C. orthopsilosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
- Department of Infectious Diseases, Toranomon Hospital, 2-2-2, Toranomon, Minato-ku, Tokyo, 105-8470, Japan. mizuki.haraguchi87@gmail.com.
- Okinaka Memorial Institute for Medical Research, Tokyo, Japan. mizuki.haraguchi87@gmail.com.
- Laboratory of Microbial Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Infectious Diseases, Toranomon Hospital, 2-2-2, Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
ORCID-Profile: Mizuki Haraguchi
Förderung
- AMED
- Okinaka Memorial Institute for Medical Research
Zitieren
APA
Hirao, T., Haraguchi, M., Yamaguchi, K., Horiba, K., Abe, M., Koizumi, A., Oiki, S., Kageyama, K., Taya, Y., Araoka, H., Miyazaki, Y., & Wake, A. (2026). First Case of Candidemia Caused by Fluconazole-Resistant Candida orthopsilosis Harboring the ERG11 G458S Mutation in a Hematopoietic Stem Cell Transplant Recipient in Asia. Mycopathologia, 191(4). https://doi.org/10.1007/s11046-026-01093-2
Vancouver
Hirao T, Haraguchi M, Yamaguchi K, Horiba K, Abe M, Koizumi A, et al. First Case of Candidemia Caused by Fluconazole-Resistant Candida orthopsilosis Harboring the ERG11 G458S Mutation in a Hematopoietic Stem Cell Transplant Recipient in Asia. Mycopathologia. 2026;191(4). doi:10.1007/s11046-026-01093-2
BibTeX
@article{Hirao2026,
author = {Hirao, Tatsuro and Haraguchi, Mizuki and Yamaguchi, Kyosuke and Horiba, Kazuhiro and Abe, Masahiro and Koizumi, Ami and Oiki, Sayoko and Kageyama, Kosei and Taya, Yuki and Araoka, Hideki and Miyazaki, Yoshitsugu and Wake, Atsushi},
title = {First Case of Candidemia Caused by Fluconazole-Resistant Candida orthopsilosis Harboring the ERG11 G458S Mutation in a Hematopoietic Stem Cell Transplant Recipient in Asia},
journal = {Mycopathologia},
year = {2026},
volume = {191},
number = {4},
doi = {10.1007/s11046-026-01093-2}
}
EUVIMED